Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Diagnostics to sell 454's sequencers:

This article was originally published in Clinica

Executive Summary

Roche Diagnostics' Applied Science unit is to distribute a genome sequencer made by CuraGen subsidiary 454 Life Sciences under a new, five-year, exclusive agreement. 454 Life Sciences, which says its system is up to 100 times faster than other commercially available sequencers, stands to receive up to $62m in licence fees, milestones, minimum royalties and research funding from Roche. Roche has an option to extend its distribution rights to cover the regulated diagnostics market.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT055156

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel